US Halts HIV Program Funding in South Africa
The United States government has announced its intention to discontinue funding for HIV and AIDS programs in South Africa. This decision is reportedly linked to the US administration's claims that the South African government has not adequately protected its white-minority Afrikaner community.
In response, South Africa's health ministry indicated that while they had not been formally notified of this development, they have been developing a "self-reliance plan" for some time. South Africa has the world's largest population living with HIV, with over eight million individuals affected.
Background of US-South Africa Relations and Funding
Historically, the U.S. has been a significant supporter of South Africa's efforts against HIV, providing an estimated $400 million annually through the President's Emergency Fund for AIDS Relief (Pepfar) until 2025. However, relations between the two nations have become strained since President Donald Trump took office.
Shortly after his inauguration, President Trump issued an executive order alleging that various South African policies undermined equal opportunities and fueled violence against "racially disfavored landowners." The South African government disputes these claims, asserting that its Black Economic Empowerment policy is crucial for addressing economic disparities rooted in the apartheid era. The executive order also referenced South Africa's case against Israel at the International Court of Justice and its connections with Iran, with the White House citing these as "unjust and immoral practices" justifying the cessation of further aid.
President Trump has also made unsubstantiated claims of a "white genocide" in South Africa, leading to the creation of a refugee program for Afrikaners, who are descendants of 17th-century Western European settlers in southern Africa. Currently, Afrikaners are among the few groups permitted entry into the US under this refugee status.
Phased Drawdown of Pepfar Funds
Last October, Pepfar funding, which accounted for approximately one-fifth of South Africa's total HIV program expenditure, received a temporary "bridge plan." However, a US State Department official has now confirmed that a "phased drawdown" of Pepfar funding will commence. This decision, according to the official, stems from "South Africa's failure to make demonstrable progress on policy requests by the administration."
The US government's stated aim is to "foster self-reliance" and reduce dependence on American funding, noting that "South Africa is a middle-income country and is more than capable of supporting its own health programs."
South Africa's health ministry has clarified that while Pepfar contributed to their HIV program, the provision of life-saving antiretroviral drugs is funded independently, primarily by the South African government.
Diplomatic Efforts and Broader Tensions
Attempts to improve US-South Africa relations have largely been unsuccessful. This includes a high-profile meeting at the White House over a year ago, where President Trump confronted South African President Cyril Ramaphosa with his claims of white persecution. The US also boycotted the G20 meeting hosted by South Africa last November.
Source: US to end funding of South Africa's HIV programmes over claims of Afrikaner persecution